Anti-IL-6
Anti-IL-6[edit | edit source]
Anti-IL-6 refers to a class of therapeutic agents that target and inhibit the activity of interleukin 6 (IL-6), a cytokine involved in inflammation and immune response. These agents are primarily used in the treatment of autoimmune diseases and certain types of cancers.
Mechanism of Action[edit | edit source]
IL-6 is a pro-inflammatory cytokine that plays a crucial role in the immune response. It is produced by various cells, including T cells, B cells, macrophages, and fibroblasts. IL-6 acts by binding to its receptor, IL-6R, which then associates with the signal-transducing component gp130, leading to the activation of the JAK-STAT signaling pathway. This pathway is involved in the regulation of immune responses, inflammation, and hematopoiesis.
Anti-IL-6 agents work by either directly binding to IL-6, preventing it from interacting with its receptor, or by blocking the IL-6 receptor itself. This inhibition reduces the inflammatory response and is beneficial in conditions characterized by excessive inflammation.
Clinical Applications[edit | edit source]
Anti-IL-6 therapies are used in the treatment of several conditions, including:
- Rheumatoid arthritis: Anti-IL-6 agents help reduce joint inflammation and pain.
- Systemic lupus erythematosus: These agents can help manage symptoms by modulating the immune response.
- Castleman's disease: Anti-IL-6 therapy is effective in treating this rare lymphoproliferative disorder.
- Cytokine release syndrome: Often associated with CAR T-cell therapy, anti-IL-6 agents can mitigate severe inflammatory responses.
Examples of Anti-IL-6 Agents[edit | edit source]
Some of the well-known anti-IL-6 agents include:
- Tocilizumab: A monoclonal antibody that targets the IL-6 receptor.
- Sarilumab: Another monoclonal antibody against the IL-6 receptor.
- Siltuximab: A monoclonal antibody that binds directly to IL-6.
Side Effects[edit | edit source]
Common side effects of anti-IL-6 therapy include:
- Increased risk of infections due to immune suppression.
- Elevated liver enzymes.
- Gastrointestinal disturbances.
- Injection site reactions.
Research and Development[edit | edit source]
Ongoing research is exploring the use of anti-IL-6 agents in other inflammatory conditions and cancers. Studies are also investigating the long-term effects and safety of these therapies.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
